The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Sabra Health Care REIT Inc

Nasdaq: SBRA
Last

(U.S.) $21.50

Today's change-0.14 -0.62%
Updated August 22 3:33 PM EDT. Delayed by at least 15 minutes.
 

Sabra Health Care REIT Inc

Nasdaq: SBRA
Last

(U.S.) $21.50

Today's change-0.14 -0.62%
Updated August 22 3:33 PM EDT. Delayed by at least 15 minutes.

Sabra Health Care REIT Inc down (U.S.)$0.14

Sabra Health Care REIT Inc is lower today, dropping (U.S.)$0.14 or 0.62% to (U.S.)$21.50. Although unchanged over the last five days, shares are down 11.98% for the last year to date. This security has underperformed the S&P 500 by 26.46% during the last year.

Key company metrics

  • Open(U.S.) $21.66
  • Previous close(U.S.) $21.63
  • High(U.S.) $21.96
  • Low(U.S.) $21.09
  • Bid / Ask(U.S.) $21.49 / (U.S.) $21.50
  • YTD % change-11.98%
  • Volume1,843,107
  • Average volume (10-day)4,776,245
  • Average volume (1-month)3,219,622
  • Average volume (3-month)2,097,668
  • 52-week range(U.S.) $19.30 to (U.S.) $29.10
  • Beta0.94
  • Trailing P/E18.20×
  • P/E 1 year forward17.42×
  • Forward PEG5.90×
  • Indicated annual dividend(U.S.) $1.72
  • Dividend yield8.00%
  • Trailing EPS(U.S.) $1.18
Updated August 22 3:33 PM EDT. Delayed by at least 15 minutes.
S&P TSX0.28%Sector:HealthcareIndustry:Healthcare Facilities

Latest Company News

Latest Press Releases

View more Press Releases
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2017Q1/2017Q4/2016Q3/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201706/30/2017Mar 31, 201703/31/2017Dec 31, 201612/31/2016Sep 30, 201609/30/2016
Revenue65636262
Total other revenue--------
Total revenue65636262
Gross profit60606061
Total cost of revenue4211
Total operating expense49464141
Selling / general / administrative12977
Research & development--------
Depreciation / amortization17191717
Interest expense (income), net operating16161616
Unusual expense (income)0000
Other operating expenses, total--------
Operating income16172121
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets40-31
Other--------
Income before tax21192325
Income after tax21192325
Income tax, total--------
Net income21192325
Total adjustments to net income-3-3-3-3
Net income before extra. items21192325
Minority interest0000
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items18162123
Inc. avail. to common incl. extra. items18162123
Diluted net income18162123
Dilution adjustment--------
Diluted weighted average shares66666666
Diluted EPS excluding extraordinary itemsvalue per share0.270.250.310.35
Dividends per sharevalue per share0.430.000.420.42
Diluted normalized EPSvalue per share0.210.250.360.33